Literature DB >> 8299769

Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III.

H Sandström1, A Wahlin, M Eriksson, I Bergström, S N Wickramasinghe.   

Abstract

A family with congenital dyserythropoietic anaemia type III was studied. Twenty patients and 10 of their healthy siblings were clinically examined and questioned about their medical history. Blood sampling and bone marrow aspirations were also performed. Forty-five percent of the patients reported symptoms of anaemia and 35% regularly felt weakness, fatigue, or headache. However, the majority of the patients regarded themselves as healthy. The bone marrow showed a uniform picture of erythroid hyperplasia with multinuclear erythroblasts and gigantoblasts with up to 12 nuclei. There was laboratory evidence of intravascular haemolysis and mild anaemia. We also observed a high prevalence of monoclonal gammopathy of undetermined significance (3 cases) and myeloma (1 case) among the patients.

Entities:  

Mesh:

Year:  1994        PMID: 8299769     DOI: 10.1111/j.1600-0609.1994.tb01283.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  10 in total

1.  Congenital dyserythropoietic anemias: III's a charm.

Authors:  Elizabeth Traxler; Mitchell J Weiss
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

2.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

Review 3.  The congenital dyserythropoieitic anemias: genetics and pathophysiology.

Authors:  Richard King; Patrick J Gallagher; Rami Khoriaty
Journal:  Curr Opin Hematol       Date:  2021-12-24       Impact factor: 3.218

4.  Malignant lymphoma in congenital dyserythropoietic anaemia type III.

Authors:  W G McCluggage; D Hull; E Mayne; H Bharucha; S N Wickramasinghe
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

5.  Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

Authors:  Ola Landgren; Sigurdur Y Kristinsson; Lynn R Goldin; Neil E Caporaso; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Magnus Bjorkholm; Ingemar Turesson
Journal:  Blood       Date:  2009-01-30       Impact factor: 22.113

Review 6.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

7.  Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.

Authors:  Manuel Méndez; María Isabel Moreno-Carralero; Valeria L Peri; Rafael Camacho-Galán; José M Bosch-Benítez; Jorge Huerta-Aragonés; Jorge Sánchez-Calero-Guilarte; María Belén Moreno-Risco; Juan Manuel Alonso-Domínguez; María José Morán-Jiménez
Journal:  Ann Hematol       Date:  2020-11-07       Impact factor: 3.673

8.  Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression.

Authors:  Ann-Louise Vikberg; Tõnu Vooder; Kaie Lokk; Tarmo Annilo; Irina Golovleva
Journal:  Onco Targets Ther       Date:  2017-10-11       Impact factor: 4.147

Review 9.  The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.

Authors:  Simon Grootendorst; Jonathan de Wilde; Birgit van Dooijeweert; Annelies van Vuren; Wouter van Solinge; Roger Schutgens; Richard van Wijk; Marije Bartels
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

Review 10.  Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature.

Authors:  Maroun Bou Zerdan; Maria Julia Diacovo; Chakra P Chaulagain
Journal:  Am J Case Rep       Date:  2021-12-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.